|
Index of reports
> Cases with Death (226)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include death. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 226 Next >>
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: male, weighing 103.1 kg (226.8 pounds)
Reactions: Plasmacytosis, Pneumonia, Mouth Haemorrhage, Pseudomonas Infection, Headache, Disease Progression, Death, Mucosal Inflammation, Pleural Effusion, Depressed Level of Consciousness, Abscess, Lethargy, RIB Fracture
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Doxorubicin Hydrochloride
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Radiation Therapy NOS
Indication: Multiple Myeloma
Revlimid
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Other drugs received by patient: Bendamustine Hydrochloride; Lenalidomide
Possible Dexamethasone side effects in male
Reported by a physician from United States on 2012-08-23
Patient: male
Reactions: Death, Chalazion
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Velcade
Dosage: 2 mg, 1/week
Indication: Multiple Myeloma
Start date: 2009-08-13
End date: 2012-01-03
Other drugs received by patient: Bisphosphonates; Travoprost
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-08-22
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: unk
Administration route: Oral
Indication: Soft Tissue Neoplasm
Trabectedin
Dosage: 1500 microgram per sq meter, q3w
Indication: Soft Tissue Neoplasm
Possible Dexamethasone side effects in
Reported by a physician from Korea, Republic of on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, cyclic
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: 9 mg/m2, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2, cyclic
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: 60 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Possible Dexamethasone side effects in
Reported by a physician from Korea, Republic of on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, cyclic
Indication: Multiple Myeloma
Doxorubicin Hydrochloride
Dosage: 9 mg/m2, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2, cyclic
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: 60 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Possible Dexamethasone side effects in
Reported by a physician from Korea, Republic of on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, cyclic
Indication: Multiple Myeloma
Doxorubicin Hydrochloride
Dosage: 9 mg/m2, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen
Possible Dexamethasone side effects in
Reported by a physician from Korea, Republic of on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, cyclic
Indication: Multiple Myeloma
Doxorubicin Hydrochloride
Dosage: 9 mg/m2, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen
Possible Dexamethasone side effects in
Reported by a physician from Korea, Republic of on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, cyclic
Indication: Multiple Myeloma
Doxorubicin Hydrochloride
Dosage: 9 mg/m2, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2, cyclic
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: 60 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-13
Patient:
Reactions: Pulmonary Embolism, Multiple Myeloma, Peripheral Sensory Neuropathy, Constipation, Somnolence, Death, Complications of Transplant Surgery, Peripheral Motor Neuropathy, Thrombosis in Device, Blood Alkaline Phosphatase Increased, Pancytopenia, Multiple Fractures, Rash, Renal Failure, Osteonecrosis of JAW, Embolism, Hypothyroidism, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Dexamethasone
Dosage: 20 milligram
Indication: Multiple Myeloma
Thalidomide
Dosage: or 4 weeks and increased every 4 weeks in 50-mg increments to a maximum of 200mg/day
Administration route: Oral
Indication: Multiple Myeloma
Other drugs received by patient: Melphalan Hydrochloride; Prednisolone; CLO; ZOL; Melphalan Hydrochloride; Biphosphonate; Vincristine; Doxorubicin Hydrochloride; Bortezomib
Possible Dexamethasone side effects in
Reported by a physician from Turkey on 2012-08-10
Patient:
Reactions: Death, Peripheral Sensorimotor Neuropathy, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Dosage: 1 mg, / day
Bortezomib
Dosage: 1.3 mg/m2 days:1,4,8,11
Indication: Multiple Myeloma
Dexamethasone
Dosage: unk, unknown
Indication: Multiple Myeloma
Hydroxyurea
Dosage: unk, unknown
Indication: Essential Thrombocythaemia
Start date: 2000-09-01
Thalidomide
Dosage: unk, unknown
Indication: Multiple Myeloma
Other drugs received by patient: Thyroid Replacement Therapy
Possible Dexamethasone side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient: female, weighing 58.0 kg (127.6 pounds)
Reactions: Dysphagia, Incorrect Dose Administered, Anaemia, Rash, Eating Disorder, Death, Decubitus Ulcer, Oral Candidiasis, Dyspepsia, Gastrooesophageal Reflux Disease, Asthenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: unk
Indication: Product Used FOR Unknown Indication
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Start date: 2012-05-12
Erlotinib Hydrochloride
Dosage: 25 mg, uid/qd
Administration route: Oral
Start date: 2012-05-07
Erlotinib Hydrochloride
Dosage: 50 mg, uid/qd
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-04-30
Other drugs received by patient: Keppra; Chemotherapy; Steroid
Possible Dexamethasone side effects in
Reported by a physician from Turkey on 2012-08-10
Patient:
Reactions: Death, Peripheral Sensorimotor Neuropathy, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Dosage: 1 mg, / day
Bortezomib
Dosage: 1.3 mg/m2 days:1,4,8,11
Indication: Multiple Myeloma
Dexamethasone
Dosage: unk, unknown
Indication: Multiple Myeloma
Hydroxyurea
Dosage: unk, unknown
Indication: Essential Thrombocythaemia
Start date: 2000-09-01
Thalidomide
Dosage: unk, unknown
Indication: Multiple Myeloma
Other drugs received by patient: Thyroid Replacement Therapy
Possible Dexamethasone side effects in male
Reported by a physician from Canada on 2012-08-09
Patient: male, weighing 84.5 kg (185.9 pounds)
Reactions: Death, Sinusitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 5.7143 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-10-27
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-10-27
Other drugs received by patient: Tylenol W / Codeine; Tinzaparin; Calcium; Benadryl; Colace; Eprex; Aspirin; Allertin; Vitamin D; Eprex; Curamin; Vitamin B Complex CAP; Ascorbic Acid; Codeine Phosphate and Acetaminophen
Possible Dexamethasone side effects in
Reported by a physician from Israel on 2012-08-08
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Multiple Myeloma
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03
Patient: male
Reactions: Back Pain, Death
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytoxan
Dosage: 1620 mg, cyclic
Indication: Multiple Myeloma
Start date: 2011-09-08
End date: 2011-09-08
Dexamethasone
Dosage: 40 mg, cyclic
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-09-08
End date: 2011-10-13
Velcade
Dosage: 2 mg, cyclic
Indication: Multiple Myeloma
Start date: 2011-09-08
End date: 2011-10-05
Possible Dexamethasone side effects in
Reported by a physician from Italy on 2012-08-03
Patient:
Reactions: Pyrexia, Constipation, Disease Progression, Liver Disorder, Herpes Zoster, Cardiac Disorder, Death, Neuropathy Peripheral, Oedema, Thrombocytopenia, Hyperglycaemia, Toxicity To Various Agents, Rash, Gastrointestinal Disorder, Pancreatitis, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.3 milligram/sq. meter
Bortezomib
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Bortezomib
Dosage: 1 milligram/sq. meter
Bortezomib
Dosage: .7 milligram/sq. meter
Dexamethasone
Dosage: 40 milligram
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Dexamethasone
Dosage: 40 milligram
Dexamethasone
Dosage: 40 milligram
Thalidomide
Dosage: 100 milligram
Administration route: Oral
Thalidomide
Dosage: 200 milligram
Administration route: Oral
Thalidomide
Dosage: 50 milligram
Administration route: Oral
Thalidomide
Dosage: 100 milligram
Administration route: Oral
Thalidomide
Dosage: 100 milligram
Administration route: Oral
Indication: Multiple Myeloma
Other drugs received by patient: Acyclovir; Melphalan Hydrochloride; Neupogen; Neupogen; Cyclophosphamide
Possible Dexamethasone side effects in male
Reported by a physician from Australia on 2012-08-02
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-02-24
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-02-24
Other drugs received by patient: Docusate Senna; Oxycontin; Lactulose; Valaciclovir; Amlodipine
Possible Dexamethasone side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient: female
Reactions: Malnutrition, Hyperglycaemia, Fall, Hepatic Enzyme Increased, Death, Oral Candidiasis, Oedema Peripheral, Urosepsis, Pulmonary Oedema, Asthenia, Acute Respiratory Failure, Escherichia Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 4 mg, bid
Indication: Metastases To Central Nervous System
Start date: 2012-05-02
Dexamethasone
Dosage: unk
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Indication: non-Small Cell Lung Cancer Stage IV
Start date: 2012-05-31
Other drugs received by patient: Duragesic-100; Folic Acid; Xanax; Celexa; Clarinex / 01202601 /; Advair; Keppra; Pepcid; Provera; Estrace; Flexeril; Vicodin; Compazine
Possible Dexamethasone side effects in
Reported by a individual with unspecified qualification from Spain on 2012-07-30
Patient:
Reactions: Colon Cancer, Pulmonary Embolism, Toxicity To Various Agents, Multiple Myeloma, Herpes Zoster, Death, Neuropathy Peripheral, Gastrointestinal Disorder, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.3mg/m2 on days 1,4,8 and 11 q 3 weeks
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40mg on days 1-4 and 9-12 at 4-week intervals
Administration route: Oral
Indication: Multiple Myeloma
Thalomid
Dosage: 200mg daily (escalating doses in the first cycle)
Administration route: Oral
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a individual with unspecified qualification from United States on 2012-07-27
Patient:
Reactions: Death, Adrenal Carcinoma
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, cyclic
Administration route: Oral
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Other drugs received by patient: Acyclovir; Acyclovir
Possible Dexamethasone side effects in male
Reported by a physician from Australia on 2012-07-23
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-02-24
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-02-24
Other drugs received by patient: Valaciclovir; Lactulose; Oxycontin; Amlodipine; Docusate Senna
Possible Dexamethasone side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Cardiac Failure Congestive, Immunosuppression, Renal Failure Acute, Pneumonia, Dyspnoea, Malnutrition, Atrial Fibrillation, Febrile Neutropenia, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
End date: 2012-04-10
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Other drugs received by patient: Doxil; Coreg; Pravastatin; Heocyte; Betaseron; Lotrel; Aspirin; Vitamin D; Warfarin Sodium; Allopurinol; Doxepin; Acyclovir; Metformin Hydrochloride; Tricore
Possible Dexamethasone side effects in
Reported by a physician from France on 2012-07-18
Patient:
Reactions: Death, Lung Infection, Myocardial Infarction
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 75 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2011-11-04
End date: 2012-02-07
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-11-04
End date: 2012-02-07
Velcade
Dosage: 2.4 mg, unk
Indication: Multiple Myeloma
End date: 2012-02-07
Other drugs received by patient: Bisoprolol Fumarate; Clopidogrel; Ezetimibe; Perindopril Erbumine; Lercanidipine; Plavix; Acetaminophen; Codeine Phosphate and Acetaminophen
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-07-16
Patient:
Reactions: Graft Versus Host Disease, Pulmonary Embolism, Toxicity To Various Agents, Polyneuropathy, Disease Progression, Death, Embolism Venous, Deep Vein Thrombosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 15 milligram/sq. meter
Adriamycin PFS
Dosage: 9 milligram/sq. meter
Indication: Multiple Myeloma
Cyclophosphamide
Dosage: 1000 milligram/sq. meter
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Melphalan Hydrochloride
Dosage: 200 milligram/sq. meter
Thalomid
Dosage: induction therapy, 200 mg escalated to 400 mg, qd, with vte prophylaxis
Administration route: Oral
Indication: Multiple Myeloma
Thalomid
Dosage: maintenance therapy, 50 mg qd, without vte prophylaxis
Administration route: Oral
Other drugs received by patient: Neupogen; Mycophenolate Mophetil; Cyclosporine; Nadroparine
Possible Dexamethasone side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Renal Failure Acute, Immunosuppression, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Atrial Fibrillation, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
End date: 2012-04-10
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Other drugs received by patient: Betaseron; Lotrel; Coreg; Doxepin; Vitamin D; Warfarin Sodium; Pravastatin; Doxil; Acyclovir; Allopurinol; Heocyte; Tricore; Aspirin; Metformin Hydrochloride
Possible Dexamethasone side effects in male
Reported by a physician from Spain on 2012-07-13
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-03-13
End date: 2012-04-09
Dexamethasone
Administration route: Oral
Start date: 2012-04-10
End date: 2012-05-07
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-03-13
End date: 2012-04-02
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2012-04-10
End date: 2012-05-07
Other drugs received by patient: Aspirin; Cefixim; Cefepim
Possible Dexamethasone side effects in male
Reported by a physician from Australia on 2012-07-12
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-02-24
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-02-24
Page 1 Next >>
|
